Related Experiment Video

Updated: Aug 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

[Prevention of reinfarction with 100 mg or 30 mg ASS daily?]

W Förster1

  • 1Instituts für Pharmakologie und Toxikologie, Martin-Luther-Universität Halle-Wittenberg, Halle.

Zeitschrift Fur Kardiologie
|May 1, 1995
PubMed

Insights

Low-dose aspirin (20-30 mg/day) effectively prevents heart infarction by selectively inhibiting thromboxane synthesis. This dosage offers superior cardioprotection with fewer side effects than higher aspirin doses.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Current German practice uses 100 mg aspirin for heart infarction prevention, based on limited evidence.
  • Higher aspirin doses may not be optimal for cardioprotection.

Purpose of the Study:

  • To evaluate the efficacy and safety of low-dose aspirin (20-30 mg/day) for heart infarction prevention.
  • To compare low-dose aspirin with higher doses.

Main Methods:

  • Review of experimental and clinical studies over 14 years.
  • Analysis of pharmacokinetic data on aspirin's effects on thromboxane and prostacyclin synthesis.
  • Inclusion of findings from the Cottbus reinfarction study.

Main Results:

  • Low-dose aspirin (20-30 mg/day) selectively inhibits thromboxane synthesis, preserving cardioprotective prostacyclin.
  • Prostacyclin exhibits antiplatelet, antifibrillatory, and adenosine-releasing effects beneficial for ischemic hearts.
  • The Cottbus study demonstrated superior preventive action and reduced side effects with 30 mg/day aspirin compared to higher doses.

Conclusions:

  • 30 mg/day aspirin is recommended to replace current higher-dose prevention strategies.
  • Low-dose aspirin offers a more targeted and safer approach to heart infarction prevention.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...